Alterity Therapeutics (ATHE) Receivables - Accured (2009 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Receivables - Accured of $4.5 million for Q4 2025, up 20.86% year-over-year from $3.7 million in Q4 2024, and up 78.15% quarter-over-quarter from $2.5 million in Q2 2025.
Alterity Therapeutics (ATHE) Receivables - Accured (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Receivables - Accured history runs 17 years deep, the most recent figure standing at $4.5 million for Q4 2025.
- In Q4 2025, Receivables - Accured rose 20.86% year-over-year to $4.5 million; the TTM figure through Dec 2025 stood at $4.5 million (up 20.86% YoY), while the FY2025 annual figure was $2.5 million, down 5.32% from the prior year.
- Receivables - Accured for Q4 2025 stood at $4.5 million, up from $2.5 million in the prior quarter.
- The five-year high for Receivables - Accured was $4.6 million in Q4 2022, with the low at $40416.8 in Q2 2024.
- The 5-year median for Receivables - Accured is $3.6 million (2022), against an average of $3.1 million.
- The sharpest annual moves came in 2021 and 2023: Receivables - Accured surged 8095.97% in 2021, then sank 97.44% in 2023.
- Alterity Therapeutics' Receivables - Accured stood at $4.6 million in 2021, then gained by 1.95% to $4.6 million in 2022, then dropped by 16.22% to $3.9 million in 2023, then fell by 4.58% to $3.7 million in 2024, then rose by 20.86% to $4.5 million in 2025.
- Business Quant data shows ATHE's Receivables - Accured at $4.5 million in Q4 2025, $2.5 million in Q2 2025, and $3.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Alterity Therapeutics | 48.08 Mn | 15.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.49 Mn |
| Dec 31, 2025 | 4.49 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Jun 30, 2024 | 40,416.75 |
| Jun 30, 2024 | 40,416.75 |
| Dec 31, 2023 | 3.90 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Jun 30, 2023 | 86,657.04 |
| Jun 30, 2023 | 86,657.04 |
| Dec 31, 2022 | 4.65 Mn |
| Dec 31, 2022 | 4.65 Mn |
| Jun 30, 2022 | 3.38 Mn |
| Jun 30, 2022 | 3.38 Mn |
| Dec 31, 2021 | 4.56 Mn |
| Dec 31, 2021 | 4.56 Mn |
| Jun 30, 2021 | 3.29 Mn |
| Jun 30, 2021 | 3.29 Mn |